Genetic Technologies Ltd has released a press release.
GTG signs 3-year US licence agreement for COVID risk test
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Pause in Trading
- 1H21 Half Year Results
- Genetic Technologies US$6.56 Million Capital Raising
- Genetic Technologies appoints Simon Morriss as CEO
- GTG Secures US and ANZ Distribution Rights for PREDICTIX
Later from Genetic Technologies
- COVID- 19 Risk Test Approved for Commercial Release
- GTG COVID-19 Risk Test launched in USA
- US Patent Office Grants Foundational Pharmacogenomic Patent
- Genetic Technologies Acquires EasyDNA
- Genetic Technologies Investor Presentation and Webinar
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies